IP Library › Assignment 040940/0494
Patent Assignment
Reel/Frame 040940/0494

Correspondents Address Correction

Recorded: 2016-12-15 Pages: 2
Assignor
Assignee
KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
4000 CENTREGREEN WAY, CENTREGREEN TWO, SUITE 300, CARY, NORTH CAROLINA, 27513
Covered Property (1)
Methods of Modifying the Bioavailability of Metaxalone
Patent: 7,714,006 →
Application: 11/182,661 →
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Nov 20, 2006
From: JONES PHARMA INCORPORATED
To: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
Reel/Frame 018621/0312 →
Security Agreement Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →
Security Agreement May 13, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 025703/0628 →
Release of Security Interest Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025738/0132 →